These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25517708)

  • 1. Images in clinical medicine. Saber tibia in Paget's disease of bone.
    Gonçalves MJ; Romão VC
    N Engl J Med; 2014 Dec; 371(25):2417. PubMed ID: 25517708
    [No Abstract]   [Full Text] [Related]  

  • 2. Paget's disease. Common cause of bone weakening.
    Mayo Clin Health Lett; 2013 Jun; 31(6):7. PubMed ID: 24716278
    [No Abstract]   [Full Text] [Related]  

  • 3. [Zoledronic acid efficacy in Paget's disease of bone: a three-year experience].
    Conesa Mateos A; Rotés Sala D; Almirall Bernabé M; Carbonell Abelló J
    Med Clin (Barc); 2006 Oct; 127(16):635-6. PubMed ID: 17145033
    [No Abstract]   [Full Text] [Related]  

  • 4. The physical therapist's leg pain: Paget's disease.
    Carlsen D; Hassan TS; Lewi JE
    Am J Med; 2015 Feb; 128(2):130-2. PubMed ID: 25448177
    [No Abstract]   [Full Text] [Related]  

  • 5. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
    Abelson A
    Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravenous bisphosphonates for bone Paget's disease: higher risk of adverse events].
    Grados D; Martínez-Morillo M; Holgado S; Erra A
    Med Clin (Barc); 2014 May; 142(10):469-70. PubMed ID: 24120108
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical practice. Paget's disease of bone.
    Whyte MP
    N Engl J Med; 2006 Aug; 355(6):593-600. PubMed ID: 16899779
    [No Abstract]   [Full Text] [Related]  

  • 8. Normal bone turnover markers in a patient with active Paget's disease of bone: response to treatment with zoledronic acid.
    Polyzos SA; Anastasilakis AD; Anagnostis P; Kita M; Arsos G; Moralidis E; Papatheodorou A; Terpos E
    Endokrynol Pol; 2012; 63(4):312-5. PubMed ID: 22933168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zoledronic acid for Paget's disease of bone.
    Maricic M
    Drugs Today (Barc); 2007 Dec; 43(12):879-85. PubMed ID: 18174973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of zoledronic acid for Paget's disease of bone.
    Maricic M
    Curr Osteoporos Rep; 2006 Mar; 4(1):40-4. PubMed ID: 16527007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A classical presentation of Paget disease of bone.
    Sheane BJ; Delaney H; Doran MF; Cunnane G
    J Clin Rheumatol; 2008 Dec; 14(6):373. PubMed ID: 19060670
    [No Abstract]   [Full Text] [Related]  

  • 12. Polyostotic Paget's disease.
    Butt ST; Fatima S; Butt R; Nasir W; Jameel G; Irfan J
    J Coll Physicians Surg Pak; 2012 Jul; 22(7):461-3. PubMed ID: 22747870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zoledronic acid: a review of its use in the treatment of Paget's disease of bone.
    Keating GM; Scott LJ
    Drugs; 2007; 67(5):793-804. PubMed ID: 17385948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent effect of zoledronic acid in Paget's disease.
    Tziomalos K; Florentin M; Krikis N; Perifanis V; Karagiannis A; Harsoulis F
    Clin Exp Rheumatol; 2007; 25(3):464-6. PubMed ID: 17631747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Paget's disease of bone].
    Holgado Pérez S; Sallés Lizarzáburu M; Olivé Marqués A
    Med Clin (Barc); 2008 Oct; 131(13):509-12. PubMed ID: 19007581
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone.
    Gennari L; Merlotti D; Mossetti G; Rendina D; De Paola V; Martini G; Nuti R
    Mini Rev Med Chem; 2009 Aug; 9(9):1052-63. PubMed ID: 19689402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual presentation of Paget's disease of bone.
    Sathyakumar S; Kapoor N; Hephzibah J; Paul TV
    BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 26944376
    [No Abstract]   [Full Text] [Related]  

  • 18. Is a single infusion of zoledronic acid more effective than oral risedronate for the treatment of patients with Paget's disease?
    Krane SM
    Nat Clin Pract Rheumatol; 2006 Apr; 2(4):186-7. PubMed ID: 16932682
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical practice. Paget's disease of bone.
    Ralston SH
    N Engl J Med; 2013 Feb; 368(7):644-50. PubMed ID: 23406029
    [No Abstract]   [Full Text] [Related]  

  • 20. Prolonged anti-resorptive activity of zoledronic acid: evidence from postmenopausal osteopenic women and patients with Paget's disease of bone.
    Polyzos SA
    Clin Rheumatol; 2011 Jan; 30(1):149-50. PubMed ID: 21053036
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.